FDA Digital Health Leader Signals Upcoming Generative AI Regulatory Guidance
Source Summary
Rick Abramson, head of digital health policy at the FDA, stated that the agency expects to issue guidance on regulatory policies for generative AI devices. The announcement signals the FDA's intent to establish clearer frameworks for this emerging technology in healthcare.
Why it matters
Regulatory guidance from the FDA will establish the framework for how generative AI devices can be developed, tested, and approved for use in healthcare.
What remains uncertain
The specific timing and detailed content of the FDA's generative AI guidance remain unspecified.
